DGX and LH Related HeadlinesGo Back
- Piper Jaffray Weighs In After CMS Published Preliminary Gap Fill Rates for NGS Panels (DGX) (ILMN) (LH) (GHDX) (QGEN)
- Myriad Genetics (MYGN) Under Pressure as Quest Diagnostics (DGX) Enters the BRCA Fray
- Quest Diagnostics (DGX), Inserm Launch 'BRCA Share'
- BofA/Merrill Lynch Downgrades Quest Diagnostics (DGX) to Underperform
- Deutsche Bank Upgrades Quest Diagnostics (DGX) to Buy; Lab Corp (LH) Cut to Hold
- Will Quest Diagnostics (DGX) Make a Move After LabCorp (LH) Scoops Up Covance (CVD)?
- Covance (CVD) Peers on Watch Following Takeover at 32% Premium
DGX and LH Related Press ReleasesGo Back
- Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers